clopidogrel and s 1033

clopidogrel has been researched along with s 1033 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ebitani, M; Monzen, T; Nagno, T; Nakaya, A; Saito, F; Yaoita, Y1

Reviews

1 review(s) available for clopidogrel and s 1033

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for clopidogrel and s 1033

ArticleYear
[A case of recurrent cerebral infarction during treatment with oral tyrosine kinase inhibitors for chronic myelogenous leukemia].
    Rinsho shinkeigaku = Clinical neurology, 2019, Jul-31, Volume: 59, Issue:7

    Topics: Administration, Oral; Aged; Aniline Compounds; Carotid Artery, Internal; Carotid Stenosis; Cerebral Infarction; Clopidogrel; Diffusion Magnetic Resonance Imaging; Enzyme Inhibitors; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Nitriles; Protein-Tyrosine Kinases; Pyrimidines; Quinolines; Recurrence; Stents

2019